Neurology startup from OrbiMed collab nabs $65M in Series A

Max Gelman

Senior Editor

Brenig Therapeutics closed a $65 million Series A on Tuesday morning, getting backing from big-name investors such as New Enterprise Associates and OrbiMed.

The company …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Neurology startup from OrbiMed collab nabs $65M in Series A

Max Gelman

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Secretive Treeline Biosciences discloses $421M financing in filing

FDA approves AbbVie's 24-hour Parkinson's infusion therapy after two CRLs

House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the ...

BenevolentAI CEO is out after less than a year on the job

Sage shakes up senior management, slashes pipeline, sheds 33% of staff

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

Neu­rol­o­gy start­up from Or­biMed col­lab nabs $65M in Se­ries A

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Neurology startup from OrbiMed collab nabs $65M in Series A